Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support
04. November 2024 14:36 ET
|
Tevogen Bio Inc
WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation
08. Oktober 2024 14:40 ET
|
Tevogen Bio Inc
The primary study endpoints were related to safety. No dose-limiting toxicities or significant adverse events related to TVGN 489, including Cytokine Release Syndrome, were observed in any patient at...
Global Liver Institute Welcomes Larry R. Holden as CEO
03. September 2024 09:54 ET
|
Global Liver Institute
Washington, DC, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the...
U.S. Emergency Medical Services (EMS) Focused Insights Report 2024-2029: A $26.2 Billion Market Driven by Rising Adoption of Telemedicine and New Government Initiatives
21. Mai 2024 09:50 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "U.S. Emergency Medical Services (EMS) Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S....
Diaphragm Pacing Therapy System Market Exhibits Substantial Growth with a 4.06% CAGR Through 2028F
23. Februar 2024 04:08 ET
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Diaphragm Pacing Therapy System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Sarcoma Drugs Industry Review 2018-2023 and Forecast 2024-2028 & 2033: Amgen, Bayer, Eisai, Eli Lilly & Company, and GlaxoSmithKline Dominate the Landscape
24. Januar 2024 13:43 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global sarcoma drugs market has grown strongly...
KJT Law Group Expands Services to Address Dental Malpractice, Extending Legal Expertise to Victims Seeking Justice
18. Januar 2024 13:30 ET
|
KJT Law Group
GLENDALE, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- KJT Law Group, proudly announces a significant expansion of its services in Southern California, specifically focusing on dental malpractice. This...
Elevar Therapeutics Joins Benefactors Council of Blue Faery, Leading Hepatocellular Carcinoma Advocacy Group
19. September 2023 09:00 ET
|
Elevar Therapeutics
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: Focus on Innovation and Treatments, COVID-19, & Pricing and Access to Medicines
09. Januar 2023 08:28 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent...
Corporate Reputation of Global Pharma Companies, 2021-2022: How do Pharma Companies Rank Two years into Covid
09. Januar 2023 07:13 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Global Edition" report has been added to ResearchAndMarkets.com's offering. ...